Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
暂无分享，去创建一个
U. Spampinato | Y. Shaham | M. Glass | R. Maldonado | Z. Justinova | G. Marsicano | F. Caraci | M. Haney | Z. Cooper | T. Kearney-Ramos | R. Serrat | F. Levin | A. Bari | M. Vallée | R. Foltin | F. Felpin | J. Revest | E. Martín-García | David B. Finlay | L. Thomsen | Marion Zanese | C. Schindler | Caroline A. Arout | Mathilde Metna | L. Bellocchio | Sandy Fabre | Daniela Cota | H. Mengel | Etienne Hebert-Chatelain | S. Monlezun | A. Cathala | Nicolas Simon | A. Busquets-García | B. Redon | P. Piazza | I. Matías | Stephanie Collins Reed | Ghislaine Campistron | Isabelle Matías | Pier Vincenzo Piazza | Arnau Busquets-García